Viewing Study NCT00272051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-01-25 @ 11:39 AM
Study NCT ID: NCT00272051
Status: COMPLETED
Last Update Posted: 2006-09-13
First Post: 2006-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
Sponsor: Sanofi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastases View
None Colorectal Neoplasms View
None Colorectal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neurotoxicity syndromes View
None Paresthesia View
None Oxaliplatin View
None Xaliproden View